Chimeric Antigen Receptor (CAR) T-cell migration and infiltration into solid tumours remains a central challenge for cancer immunotherapy. While factors such as chemokine gradients, extracellular matrix (ECM) stiffness, and immunosuppressive...
Abrego et al. (Thu,) studied this question.